|
Mike - Thanks for your input. While I agree with your views, generally, I wouldn't for a moment consider buying KOOP anywhere near these levels. I don't think we're close to a bottom because I believe there is a critical, fundamental flaw in KOOP's business plan, as I and others have discussed on this thread recently. If the stock price were to remain high, KOOP could probably acquire some revenue-producing businesses, as PartyTime has suggested. With their "currency" (stock) devalued, however, acquisitions become much tougher. It's similar, conceptually, to what befell physician practice management companies (FPAM, CMI, Phymatrix, etc.) 1-2 years ago. Between the company Westpacific referred to, the one I'm heavily invested in (StayHealthy.com), Healtheon, and other future competitors that can develop significant revenue streams other than advertising revenues, my personal opinion is that the Internet health-care companies that are exclusively "information providers" are doomed, regardless of their name recognition. -Eric |
